207 related articles for article (PubMed ID: 29603128)
1. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
Croteau SE; Liang MG; Kozakewich HP; Alomari AI; Fishman SJ; Mulliken JB; Trenor CC
J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490
[TBL] [Abstract][Full Text] [Related]
3. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma without cutaneous involvement.
Ji Y; Chen S; Li L; Yang K; Xia C; Li L; Yang G; Kong F; Lu G; Liu X
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2475-2484. PubMed ID: 30293120
[TBL] [Abstract][Full Text] [Related]
5. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
6. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
Ji Y; Chen S; Yang K; Xia C; Peng S
J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management.
Ji Y; Chen S; Xia C; Zhou J; Jiang X; Xu X; Yang K; Zhang X; Kong F; Lu G; Zhang Y
Orphanet J Rare Dis; 2020 Nov; 15(1):313. PubMed ID: 33160383
[TBL] [Abstract][Full Text] [Related]
10. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
[TBL] [Abstract][Full Text] [Related]
11. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
[TBL] [Abstract][Full Text] [Related]
12. Kaposiform haemangioendothelioma of the head and neck.
Wong BL; Lee VN; Tikka T; Kim D; Dwivedi RC
Crit Rev Oncol Hematol; 2016 Aug; 104():156-68. PubMed ID: 27365122
[TBL] [Abstract][Full Text] [Related]
13. Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon.
Martyanov AA; Tesakov IP; Khachatryan LA; An OI; Boldova AE; Ignatova AA; Koltsova EM; Korobkin JD; Podoplelova NA; Svidelskaya GS; Yushkova E; Novichkova GA; Eble JA; Panteleev MA; Kalinin DV; Sveshnikova AN
Blood Adv; 2023 Sep; 7(17):4936-4949. PubMed ID: 37307200
[TBL] [Abstract][Full Text] [Related]
14. Kaposiform Hemangioendothelioma with Bone Destruction: A 16-Year Follow-Up Cohort Study of the Clinical Characteristics and Prognosis.
Qiu T; Zhang Z; Liu J; Zhou J; Gong X; Lan Y; Zhang X; Chen S; Ji Y
J Pediatr Surg; 2024 Apr; 59(4):599-604. PubMed ID: 38158257
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonography and magnetic resonance imaging features of kaposiform hemangioendothelioma and tufted angioma.
Gong X; Ying H; Zhang Z; Wang L; Li J; Ding A; Zhou L; Lin X; Xiong P
J Dermatol; 2019 Oct; 46(10):835-842. PubMed ID: 31373042
[TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
Croteau SE; Gupta D
Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
[TBL] [Abstract][Full Text] [Related]
17. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
[TBL] [Abstract][Full Text] [Related]
18. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.
Drolet BA; Trenor CC; Brandão LR; Chiu YE; Chun RH; Dasgupta R; Garzon MC; Hammill AM; Johnson CM; Tlougan B; Blei F; David M; Elluru R; Frieden IJ; Friedlander SF; Iacobas I; Jensen JN; King DM; Lee MT; Nelson S; Patel M; Pope E; Powell J; Seefeldt M; Siegel DH; Kelly M; Adams DM
J Pediatr; 2013 Jul; 163(1):285-91. PubMed ID: 23796341
[No Abstract] [Full Text] [Related]
19. Kaposiform hemangioendothelioma: current knowledge and future perspectives.
Ji Y; Chen S; Yang K; Xia C; Li L
Orphanet J Rare Dis; 2020 Feb; 15(1):39. PubMed ID: 32014025
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
